GB202103970D0 - Formulation - Google Patents
FormulationInfo
- Publication number
- GB202103970D0 GB202103970D0 GBGB2103970.6A GB202103970A GB202103970D0 GB 202103970 D0 GB202103970 D0 GB 202103970D0 GB 202103970 A GB202103970 A GB 202103970A GB 202103970 D0 GB202103970 D0 GB 202103970D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2103970.6A GB202103970D0 (en) | 2021-03-22 | 2021-03-22 | Formulation |
PCT/EP2021/058047 WO2021198116A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
KR1020227038253A KR20230024883A (en) | 2020-04-01 | 2021-03-26 | formulation |
AU2021247378A AU2021247378A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
EP21715583.7A EP4125805A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
JP2022560085A JP2023520229A (en) | 2020-04-01 | 2021-03-26 | pharmaceutical formulation |
MX2022012359A MX2022012359A (en) | 2020-04-01 | 2021-03-26 | Formulation. |
CA3172166A CA3172166A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
CN202180035793.9A CN115701983A (en) | 2020-04-01 | 2021-03-26 | Formulations |
IL296909A IL296909A (en) | 2020-04-01 | 2021-03-26 | Formulation |
US17/995,053 US20230190685A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
BR112022019521A BR112022019521A2 (en) | 2020-04-01 | 2021-03-26 | FORMULATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2103970.6A GB202103970D0 (en) | 2021-03-22 | 2021-03-22 | Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202103970D0 true GB202103970D0 (en) | 2021-05-05 |
Family
ID=75689797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2103970.6A Ceased GB202103970D0 (en) | 2020-04-01 | 2021-03-22 | Formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202103970D0 (en) |
-
2021
- 2021-03-22 GB GBGB2103970.6A patent/GB202103970D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202007546D0 (en) | Formulation | |
GB201902551D0 (en) | Formulation | |
GB201913232D0 (en) | Aerosolisable formulation | |
GB2599912B (en) | New formulation | |
GB2595300B (en) | Novel Formulation | |
GB2595453B (en) | Novel Formulation | |
IL307849A (en) | Sotorasib formulation | |
IL308046A (en) | Alpelisib formulation | |
GB202108165D0 (en) | Formulation | |
GB202107439D0 (en) | Formulation | |
GB202107203D0 (en) | Formulation | |
GB202103970D0 (en) | Formulation | |
GB202102636D0 (en) | Formulation | |
GB202102408D0 (en) | Formulation | |
GB202016274D0 (en) | Formulation | |
GB202010573D0 (en) | Formulation | |
GB202006008D0 (en) | Aerosolisable formulation | |
GB202005340D0 (en) | Formulation | |
GB202003048D0 (en) | Formulation | |
IL305977A (en) | Formulation comprising ceralasertib | |
GB202115303D0 (en) | New formulation | |
GB202108181D0 (en) | New formulation | |
GB202007620D0 (en) | Novel formulation | |
GB202318884D0 (en) | Formulation | |
GB202316857D0 (en) | Cannabinoid-based formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |